UNSPSC 51285507: Heliomycin

This classification denotes an antibiotic with the molecular formula C22H16O6, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 7N3A092A5X, chemically known as 2h-benzo(cd)pyrene-2,6(1h)-dione, 3,5,7,10-tetrahydroxy-1,1,9-trimethyl- but more generally known as heliomycin, which bears U.S. National Institutes of Health Compound Identifier 5282060. The European Medicines Agency schedules Heliomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08013MIG.

UNSPSC 51285507 Heliomycin, a Commodity code, does not align with the state and local pharmaceutical procurement activity currently tagged under it. The recent opportunities record shows Illinois Department of Public Health and Seminole County, Florida pursuing antibiotics (Doxycycline Hyclate, Ciprofloxacin Hydrochloride) and naloxone through piggyback cooperative purchasing and competitive bidding, but neither solicitation involves heliomycin or references it by name or therapeutic class. The code's nominal scope—a specific antibiotic product—does not match the actual work being bought under this code tag in state and local procurement systems today.

The geographic activity shown spans Illinois and Florida. Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets through an Invitation for Bid process; the initial term is 12 months with two optional renewal years. Seminole County, Florida released an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building, requiring all shipping costs in vendor proposals and imposing E-Verify and drug-free workplace compliance. The mismatch between the code name and the actual pharmaceutical products being solicited suggests a tagging error in the source data; vendors evaluating this code should verify whether the intended commodity scope is general antibiotics and emergency-response pharmaceuticals rather than heliomycin specifically.